Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal ECMO: Current controversies and trends.

Jesse W Ford1

  • 1Arkansas Children's Hospital, NICU, Little Rock 72202, USA. fordjessew@uams.edu

Neonatal Network : NN
|August 18, 2006
PubMed
Summary

Extracorporeal membrane oxygenation (ECMO) use in neonates has declined due to new therapies, but sicker infants still require it. Guidelines are needed for earlier ECMO initiation in complex cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Noninvasive cerebral oximeter as a surrogate for mixed venous saturation in children.

Pediatric cardiology·2007
See all related articles

Area of Science:

  • Neonatal medicine
  • Cardiopulmonary support
  • Pediatric critical care

Background:

  • Extracorporeal membrane oxygenation (ECMO) has been a vital life support for neonatal respiratory and cardiac dysfunction since 1982.
  • Historically, its application in neonatal respiratory disease saw significant growth.
  • ECMO enables the heart and lungs to rest during critical illness.

Observation:

  • A notable downward trend in neonatal respiratory ECMO cases has emerged in recent years.
  • Fewer neonates with conditions like persistent pulmonary hypertension of the newborn (PPHN), meconium aspiration syndrome, respiratory distress syndrome, and sepsis require ECMO.
  • This decline is largely attributed to advancements in respiratory therapies such as surfactant, high-frequency oscillatory ventilation, and inhaled nitric oxide.

Findings:

  • Neonates currently requiring ECMO are generally sicker, necessitating more complex and prolonged treatment courses.
  • Congenital diaphragmatic hernia, PPHN, and sepsis consistently represent a significant portion of ECMO recipients.
  • Newer respiratory therapies have not equally impacted the need for ECMO in these specific complex neonatal conditions.

Implications:

  • The evolving landscape of neonatal respiratory care necessitates updated guidelines for ECMO utilization.
  • Earlier identification and initiation of ECMO may be crucial for improving outcomes in neonates with severe, complex conditions.
  • Further research is needed to refine patient selection criteria for ECMO to optimize its application in critical neonatal care.

Related Experiment Videos